Refine your search
Collections
Co-Authors
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Kirloskar, Madhuri
- Study of Diabetic Ketoacidosis with Special References to the Biochemical Prognostic Marker
Abstract Views :92 |
PDF Views:58
Authors
Affiliations
1 Former PG Resident, Department of Internal Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, IN
2 Associate Professor, Department of Internal Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, IN
3 Professor, Department of Internal Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, IN
1 Former PG Resident, Department of Internal Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, IN
2 Associate Professor, Department of Internal Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, IN
3 Professor, Department of Internal Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, IN
Source
MVP Journal of Medical Sciences, Vol 8, No 1 (2021), Pagination: 124-131Abstract
Background: Diabetes Mellitus is a clinically and genetically heterogeneous group of metabolic disorders that manifest in an abnormally high level of glucose in the blood. Diabetic Ketoacidosis (DKA) represent extremes in the spectrum of decompensated diabetes. The mortality in patients with Diabetic Ketoacidosis is rarely caused by a metabolic complication of hyperglycemia or metabolic acidosis and it is usually related to the underlying medical illness that precipitates metabolic compensation. The second most important contributor to the development of DKA is inadequate insulin treatment, commonly seen as a result of noncompliance, especially in the young population. Methods: The present study was conducted for period of 2 years. It is a hospital based prospective observational study of 60 Diabetic Ketoacidosis patients. The biochemical prognostic markers were studied. Results: The study was done for 60 patients diagnosed with Diabetic Ketoacidosis presented to the medicine department. The mean age was 55.44 years. So from the current study it was proved that, serum phosphorus and APACHE II score can be used for predicting the prognosis in the the DKA patients. The mean serum phosphate among the deceased patients (n = 8) was more as compared to the discharged patients (n = 52). Out of 60 patients, highest patients (n = 38) had infection (AFI, LRTI, pneumonia. UTI, sepsis pancreatitis, enterocolitis, AKI, viral fever) as their precipitating factors. Conclusion: APACHE II score and serum phosphorus is an important biochemical marker in the prognosis of DKA. APACHE II score is directly proportional to mortality index in DKA.Keywords
APACHE II, Diabetic Ketoacidosis, Glasgow Coma Scale, Serum PhosphateReferences
- Delaney MF, Zisman A, Kettyle WM. Diabetic Ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome. Endocrinol Metab Clin North Am. 2000; 29:683–705 https://doi.org/10.1016/S0889-8529(05)70159-6
- Gosmanov AR. et al. Hyperglycemic Crises: Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar State (HHS). NCBI. 2018.
- Oldenhuis CN1, Oosting SF, Gietema JA, de Vries EG. Prognostic versus predictive value of biomarkers in oncology. Eur J Cancer. 2008; 44(7):946–53. PMid: 18396036. https://doi.org/10.1016/j.ejca.2008.03.006
- Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE I1: a severity of disease classification system. Crit Care Med 1985; 13:818–29. PMid: 3928249. https://doi.org/10.1097/00003246-198510000-00009
- Zimmerman JE. APACHE III study design: Analytic plan for evaluation of severity and outcome. Crit Care Med. 1989; 17:S169–221. PMid: 2591237. https://doi.org/10.1097/00003246-198912001-00002
- Matoo VK, et al. Clinical profile and treatment outcome of Diabetic Ketoacidosis. Journal of the Association of Physicians of India. 1991; 39(5):379–81.
- Agarwal A, Ambul Y, Manish G. Prognostic factors in patients hospitalized with Diabetic Ketoacidosis. Endocrinol Metab (Seouli). 2016 Sep; 31(3):1–8. PMid: 27586452 PMCid: PMC5053055. https://doi.org/10.3803/ EnM.2016.31.3.424
- Bedaso A. et al. Diabetic Ketoacidosis among adult patients with Diabetes Mellitus admitted to emergency unit of Hawassa university comprehensive specialized hospital. BMC. 2019; 12. PMid: 30871605 PMCid: PMC6419397. https://doi. org/10.1186/s13104-019-4186-3
- Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA. Hyperglycemic crises in adult patients with diabetes: A consensus statement from the American Diabetes Association. Diabetes Care. 2006; 29:2739–48. [PubMed]. PMid: 17130218. https://doi.org/10.2337/dc06-9916
- Barski L, Nevzorov R, Harman-Boehm I, Jotkowitz A, Rabaev E, Zektser M, et al. Comparison of Diabetic Ketoacidosis in patients with type-1 and type-2 Diabetes Mellitus. Am J Med Sci. 2013; 345:326–30. [PubMed]. PMid: 23377164. https://doi.org/10.1097/MAJ.0b013e31827424ab
- Efstathiou SP, Tsiakou AG, Tsioulos DI, Zacharos ID, Mitromaras AG, Mastorantonakis SE, et al. A mortality prediction model in Diabetic Ketoacidosis. Clinical Endocrinology. 2002; 57(5):595–601. [PubMed] [Google Scholar]. PMid: 12390332. https://doi.org/10.1046/j.1365-2265.2002.01636.x
- Mahesh MG, Shivaswamy RP, Chandra BS, Syed S. The study of different clinical pattern of Diabetic Ketoacidosis and common precipitating events and independent mortality factors. J Clin Diagn Res. 2017; 11(4):OC42–6. PMid: 28571190 PMCid: PMC5449836. https://doi.org/10.7860/ JCDR/2017/25347.9760
- Ahuja W, Kumar N, Kumar S, Rizwan A. Precipitating risk factors, clinical presentation, and outcome of Diabetic Ketoacidosis in patients with type 1 diabetes. Cureus. 2019; 11(5). PMid: 31372327 PMCid: PMC6669022. https://doi. org/10.7759/cureus.4789
- Hartalkar A, Hartalkar S, Peshwe K, Nath B. Profile of precipitating factors in Diabetic Ketoacidosis: Data from a rural teaching hospital. Journal of Preventive Medicine and Holistic Health. 2015 Jul-Dec; 1(2):92–5. https://doi. org/10.5958/2394-6776.2016.00001.1
- Rahim M, Uddin K, Zaman S, Musa A, Rahman M, Hossain M et al. Clinical spectrum and management of Diabetic Ketoacidosis: Experience in a tertiary care hospital. Birdem Med J 2011; 1(1):15–20. https://doi.org/10.3329/birdem. v1i1.12380
- Otieno CF, Kayima JK, Mbugua PK, Amayo AA, Mcligeyo SO. Prognostic factors in patients hospitalised with Diabetic Ketoacidosis at Kenyatta National Hospital, Nairobi. East Afr Med J. 2010; 87:66–73. [PubMed]. https:// doi.org/10.4314/eamj.v87i2.60600
- Rahim MA. et al. Clinical characteristics and outcome of Diabetic Ketoacidosis: Experience at BIRDEM, Dhaka, Bangladesh. Bangladesh Crit Care J. 2015 Sep; 3(2):53–6. https://doi.org/10.3329/bccj.v3i2.25110
- Kebler R, McDonald FD. Dynamic changes in serum phosphorus levels in Diabetic Ketoacidosis. 1985 Nov; 79(5):571–6. https://doi.org/10.1016/0002- 9343(85)90053-1
- Ellemann K, Soerensen JN, Pedersen L, Edsberg B, Andersen OO. Epidemiology and treatment of Diabetic Ketoacidosis in a community population. Diabetes Care. 1984; 7:528–32. [PubMed]. PMid: 6439530. https://doi. org/10.2337/diacare.7.6.528
- Freire AX, Umpierrez GE, Afessa B, Latif KA, Bridges L, Kitabchi AE. Predictors of intensive care unit and hospital length of stay in Diabetic Ketoacidosis. J Crit Care. 2002; 17(4):207–11. PMid: 12501147. https://doi.org/10.1053/ jcrc.2002.36755
- Study of the Risk Factors for Coronary Artery Disease and their Correlation with Thyroid Hormone Profile amongst Women with ST Segment Elevation in Acute Myocardial Infarction
Abstract Views :98 |
PDF Views:60
Authors
Affiliations
1 Professor, Department of General Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, IN
2 Former PG Resident, Department of General Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, IN
3 Associate Professor, Department of General Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, IN
1 Professor, Department of General Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, IN
2 Former PG Resident, Department of General Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, IN
3 Associate Professor, Department of General Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, IN
Source
MVP Journal of Medical Sciences, Vol 8, No 1 (2021), Pagination: 140–146Abstract
Background: Thyroid hormone has a major role in the cardiovascular function and cardiac hemodynamics as well as to maintain the cardiovascular homeostasis. The present study was planned to assess risk factors for coronary artery disease and their correlation with thyroid hormone profile amongst women with ST segment elevation in acute myocardial infraction. Material and Methods: A total number of 78 females having ST elevation myocardial infarction diagnosed through detailed clinical history and ECG evaluations were included after they satisfy the eligibility criteria. Patients were subsequently evaluated for presence of risk factors of ischemic heart disease such age, marital status, parity, and menopause, use of oral contraceptives, family history, obesity, diabetes mellitus, hypertension, hypercholesterolemia and hypertriglyceridemia. Their thyroid hormone profiles (T3, T4, TSH) were done and were correlated with risk factors for ischemic heart disease. Results: A total 78 patient included in the study most of the study population belongs to the age group of 40 to 50 years (43.6 %). Hypertension was the most common clinical features amongst study population (59%) followed by Diabetes (50%). Most of the study population had Normal Thyroid status (57.69%) followed by Hypothyroidism (25.64%) and Hyperthyroidism (16.67%) and SERUM TSH is the most sensitive test for evaluation. Diabetes Mellitus was statistically significant risk factor (p valueConclusion: Patients with coronary artery disease especially in the presence of other risk factors should be screened for thyroid dysfunction specially diabetes. We recommend tests for thyroid disorders in acute coronary syndrome can give predictor for risk of morbidity and mortality in those subjects.Keywords
MI-Myocardial Infarction, Hyperthyroidism, Hypothyroidism, STEMI-ST- Segment Elevation Myocardial Infarction, TSH- Thyroid Stimulating HormoneReferences
- Heart Disease and Stroke Statistics-2009 Update: A Report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.
- Kim ESH, Carrigan TP, Menon V; Enrollmentof women in National Heart, Lung, and Blood Institute-funded cardiovascular randomized controlled trials fails to meet current federal mandates for inclusion. J Am Coll Cardiol. 2008; 52(8):672-3. https://doi.org/10.1016/j. jacc.2008.05.025 PMid:18702973
- Pepine CJ. Ischemic heart disease in women. J Am Coll Cardiol. 2006; 47:S1-S3. https://doi.org/10.1016/j. jacc.2005.10.022 PMid:16458166
- Mikhail GW. Coronary heart disease in women. BMJ. 2005; 331(7515):467-8. https://doi.org/10.1136/bmj.331.7515.467 PMid:16141136 PMCid:PMC1199011
- Wenger NK. Coronary heart disease: The female heart is vulnerable. Prog Cardiovasc Dis. 2003; 46(3):199-299. https://doi.org/10.1016/j.pcad.2003.08.003 PMid:14685940
- Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses health study. N Engal J Med. 1991; 325:756-762. https://doi. org/10.1056/NEJM199109123251102 PMid:1870648
- Stamfer MJ, Colditz GA; Estrogen replacement therapy and coronary heart disease: Quantitative assessment of the epidemiologic evidence. Prev Med. 1991; 20(1):47-63. https://doi.org/10.1016/0091-7435(91)90006-P
- Enas EA, Senthilkumar A, Juturu V, Gupta R. Coronary artery disease in women. Indian Heart J. 2001; 53:282-92.
- O’Toolee ML. Exercise and physical activity. In Douglas PS editor. Cardiovascular health and disease in women. Philadelphia: W. B. Saunders; 1993.p. 253-68.
- Manson JE, Colditz GA, Stamfer MJ, Willet WC, Rosner B, Manson RR. A prospective study of obesity and risk of coronary heart disease in women. N Engl JMed. 1990; 322(13):882-889. https://doi.org/10.1056/ NEJM199003293221303 PMid:2314422
- Danzi S, Klein I. Thyroid disease and the cardiovascular system. Endocrinol Metab Clin North Am. 2014; 43(2):517- 28. doi: 10.1016/j.ecl.2014.02.005. https://doi.org/10.1016/j. ecl.2014.02.005 PMid:24891175
- Fazio S, Palmieri EA, Lombardi G, Biondi B. Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res. 2004; 59:31-50. https://doi.org/10.1210/ rp.59.1.31 PMid:14749496
- Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007; 116(15):1725-35. https://doi.org/10.1161/ CIRCULATIONAHA.106.678326 PMid:17923583
- Danzi S, Klein I. Alterations in thyroid hormones that accompany cardiovascular disease. Clinical Thyroidology. 2009; 21(1):3-5.
- Boekholdt SM, Titan SM, Wiersinga WM, Chatterjee K, Basart DC, Luben R, et al. Initial thyroid status and cardiovascular risk factors: The EPIC-Norfolk prospective population study. Clin Endocrinol (Oxf). 2010; 72(3):404- 10. https://doi.org/10.1111/j.1365-2265.2009.03640.x PMid:19486022
- Ertek S, Cicero AF. Hyperthyroidism and cardiovascular complications: A narrative review on the basis of pathophysiology. Arch Med Sci. 2013; 9(5):944-52. https://doi.org/10.5114/aoms.2013.38685 PMid:24273583 PMCid:PMC3832836
- Pimentel RC, Cardoso GP, Escosteguy CC, Abreu LM. Thyroid hormone profile in acute coronary syndromes. Arq Bras Cardiol. 2006; 87(6):688-94. https://doi.org/10.1590/ S0066-782X2006001900002
- Coceani M. Heart disease in patients with thyroid dysfunction: hyperthyroidism, hypothyroidism and beyond. Anadolu Kardiyol Derg. 2013; 13(1):62-6. https:// doi.org/10.5152/akd.2013.008 PMid:23086805
- Grais IM, Sowers JR. Thyroid and the heart. Am J Med. 2014; 127(8):691-8. https://doi.org/10.1016/j. amjmed.2014.03.009 PMid:24662620 PMCid:PMC4318631
- Biondi B, Klein I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine. 2004; 24(1):1-13. https://doi.org/10.1385/ENDO:24:1:001
- Yang L, Zou J, Zhang M, Xu H, Qi W, Gao L, et al. The relationship between thyroid stimulating hormone within the reference range and coronary artery disease: Impact of age. Endocr J. 2013; 60(6):773-9. https://doi.org/10.1507/ endocrj.EJ12-0448 PMid:23470525
- Thom T, Hasse N, Rosamond W. Heart disease and stroke statistics-2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006; 113:e85. https:// doi.org/10.1161/CIRCULATIONAHA.105.171600 PMid:16407573
- Kreatsoulas Catherine, Sloane Debi, Pogue Janic, Velianou James L., Anand Sonia S. Referrals in acute coronary events for cardiac catheterization: The RACE CAR Trial. Can J Cardiol. 2010; 8:e290-e296. https://doi.org/10.1016/S0828- 282X(10)70436-0
- Thom T, Hasse N, Rosamond W. Heart disease and stroke statistics-2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006; 113:e85. https://doi. org/10.1161/CIRCULATIONAHA.105.171600 PMid:1640 7573
- Braverman LE, Cooper D. 7th ed. Wolters Kluwer Health. Werner & Ingbar’s The Thyroid: A Fundamental and Clinical Text; 2012.
- Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab. 2003; 88(6):2438- 44. https://doi.org/10.1210/jc.2003-030398 PMid:12788839
- Taylor PN, Razvi S, Pearce SH, Dayan CM. Clinical review: A review of the clinical consequences of variation in thyroid function within the reference range. J Clin Endocrinol Metab. 2013; 98:3562-3571 https://doi.org/10.1210/jc.2013- 1315 PMid:23824418
- Sahni M, Kumar R, Thakur S, Bhardwaj R. Clinical profile, risk factors and shortterm outcome of acute myocardial infraction in females: A hospital based study. Heart India. 2013; 173-7
- Nanjappa V et al. Clinical profile and 30-day outcome of women with acute coronary syndrome as a first manifestation of ischemic heart disease: A single-center observational study. Indian Heart J. 2016 Mar-Apr; 68(2):164-8. https://doi.org/10.1016/j.ihj.2015.08.006 PMid:27133325 PMCid:PMC4867941
- Castelli WP, Kanel WB. Cardiovascular disease in women. Am J Obstet Gynecol. 1988; 138:1553. https://doi. org/10.1016/0002-9378(88)90189-5
- Rana M, Pandey M, Devpura G. Study of risk factors for st segment elevation myocardial infarction and it’s correlation with thyroid functions profile. Ann Int Med Den Res. 2018; 4(2):ME53-55. https://doi.org/10.21276/ aimdr.2018.4.2.ME13
- Stephen SA, Darney BG, Rosenfeld AG. Symptoms of Acute Coronary Syndrome in Women with Diabetes: An Integrative Review of the Literature. Heart Lung. 2008; 37:179-89. http://dx.doi.org/10.1016/j.hrtlng.2007.05.006 PMid:18482629
- Culic V, Eterovic D, Miric D, Silic N. Symptom presentation of acute myocardial infarction: influence of sex, age, and risk factors. American Heart Journal. 2002; 144:1012-7. https://doi.org/10.1067/mhj.2002.125625 PMid:12486425
- Jamee A, Abed Y, Jalambo MO. Gender difference and characteristics attributed to coronary artery disease in gazapalestine. Global Journal of Health Science. 2013; 5:51-6. https://doi.org/10.5539/gjhs.v5n5p51 PMid:23985106 PMCid:PMC4776843
- Jousilahti P, Vartiainen E, Tiromilehto J, Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease: A prospective follow up study of 14,786 middle aged men and women in Finland. Circulation. 1999; 99(9):1165-72. https://doi.org/10.1161/01.CIR.99.9.1165 PMid:10069784
- Sowers JR. Diabetes mellitus and cardiovascular disease in women. Arch Intern Med. 1998; 158:617-621. https://doi. org/10.1001/archinte.158.6.617 PMid:9521226
- Dhar M, Dwivedi S, Agarwal MP, Rajpal S. Clinical profile of coronary artery disease in women. Indian J Cardiology. 2006; 9:18-23.
- Bettegowda S. Clinical profile of ischemic heart disease in women with special reference to the risk factors sch. J App Med Sci. 2014; 2(6C):3020-5.
- Colditz GA, Bonita R, Stamfer MJ, Willet WC, Rosner B, Speizer FE, Hennekens CH. Cigarette smoking and risk of stroke in middle aged women. N Engl J Med. 1988; 318(15):937-41. https://doi.org/10.1056/ NEJM198804143181501 PMid:3352685
- Kaul U, Dogra B, Manchanda SC, Wasir HS, Rajani M, Bhatia ML. Myocardial infarction in young Indian patients: Risk factors and coronary arteriographic profile. Am Heart J. 1986; 112(1):75-75. https://doi.org/10.1016/0002- 8703(86)90680-0
- Study of Incidence and Prevalence of Diabetic Peripheral Neuropathy in Type II Diabetes Mellitus by Bedside Screening Techniques at a Tertiary Care Centre
Abstract Views :122 |
PDF Views:54
Authors
Affiliations
1 Former PG Resident, Department of Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, Maharashtra, IN
2 Professor, Department of Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, Maharashtra, IN
3 Associate Professor, Department of Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, Maharashtra, IN
1 Former PG Resident, Department of Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, Maharashtra, IN
2 Professor, Department of Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, Maharashtra, IN
3 Associate Professor, Department of Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, Maharashtra, IN
Source
MVP Journal of Medical Sciences, Vol 8, No 2 (2021), Pagination: 253–257Abstract
Introduction: Diabetes mellitus commonly leads to peripheral neuropathy in patients with chronically high blood sugar levels. Diabetic peripheral neuropathy leads to numbness, loss of sensation or may have extremely painful symptoms. In some patients there might be marked neuropathic deficit which may be unnoticed. Objectives: Hence to evaluate patients with diabetes mellitus helps in early screening of peripheral neuropathy. Methodology: This involves using the bedside screening techniques like monofilament test, biothesiometer, tuning fork test and diabetic symptom and examination questioner. Results: Diabetic neuropathy was most commonly present in poor control of diabetes (67%) followed by fair control (24%) and good control (9%). It was observed that severity of peripheral neuropathy was related with blood sugar. With high frequency of patients leading to diabetic peripheral neuropathy the observation is that morbidity remains high in such patients. Conclusion: Diabetic peripheral neuropathy is a major complication of diabetes mellitus. Rapid diagnosis and management are important, since recent modalities include like tricyclic antidepressants or anticonvulsants and optimal glycemic control can improve outcome of these patients. Early diagnosis of diabetic peripheral neuropathy is considered at risk of foot ulcerations and must receive preventive education and care.Keywords
Bedside Screening, Biothesiometer, Monofilament, Peripheral Neuropathy, Tuning Fork Test, Type 2 Diabetes MellitusReferences
- American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2015; 38(Suppl 1):S1-S94
- Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med. 2013; 368:1613-24. https://doi.
- org/10.1056/NEJMsa1213829. PMid:23614587
- Stellefson M, Dipnarine K, Stopka C. The chronic care model and diabetes management in US primary care settings: A systematic review. Prev Chronic Dis 2013; 10:E26.
- https://doi.org/10.5888/pcd10.120180. PMid:23428085 PMCid:PMC3604796
- Piatt GA, Anderson RM, Brooks MM, et al. 3 year follow-up of clinical and behavioral improvements following a multifaceted diabetes care intervention: Results of a randomized controlled trial. Diabetes Educ. 2010; 36:301-9. https://doi.
- org/10.1177/0145721710361388. PMid:20200284
- Merskey H, Bogduk N. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms, 2nd ed. Seattle: IASP Press; 1994. p. 209-14.
- Dyck PJ, Thomas PK. Disease of peripheral nervous system. In: Ehlers J, editor. Peripheral Neuropathy. 4 th ed.
- Philadelphia: Elsevier Saunders; 1999. p. 1135-37.
- Tesfaye S, Vileikyte L, Rayman G, Sindrup S, Perkins B, Baconja M, et al. On behalf of the Toronto Expert Panel on Diabetic Neuropathy. Painful diabetic peripheral neuropathy: Consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev. 2011. https://doi.org/10.1002/dmrr.1225. PMid:21695762
- Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care. 2011; 34:2220-4. https://doi.org/ 10.2337/dc11-1108. PMid:21852677 PMCid:PMC3177727
- Bansal V, Kalita J, Misra UK. Diabetic neuropathy.
- Postgrad Med J. 2006; 82:95-100. https://doi.org/10.1136/ pgmj.2005.036137. PMid:16461471 PMCid:PMC2596705
- Ashok S, Ramu M, Deepa R, Mohan V. Prevalence of neuropathy in type 2 diabetic patients attending a diabetes centre in South India. J Assoc Physicians India. 2002; 50:546-50.
- Yach D, Stuckler D, Brownell KD. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nature Medicine 2006; 12(1):62-6. https://doi.
- org/10.1038/nm0106-62. PMid:16397571
- Creager MA, Luscher TF, Cosentino F, Beckman H.
- Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I. Circulation.
- ; 108(12):1527-32. https://doi.org/10.1161/01.CIR.
- 27563.32. PMid:14504252
- American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care. 2013; 36(Suppl 1):S11-66.
- https://doi.org/10.2337/dc13-S011. PMid:23264422 PMCid: PMC3537269
- Boulton AJ, Gries FA, Jervell JA. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabetes Medicine. 1998; 15(6):508-14. https:// doi.org/10.1002/(SICI)1096-9136(199806)15:6<508::AIDDIA613>3.0.CO;2-L
- Soliman E, Gellido C. Diabetic Neuropathy. eMedicine.
- com; March 29, 2002. Dorsey RR, Eberhardt MS, Gregg EW, Geiss LS. Control of risk factors among people with diagnosed diabetes, by lower extremity disease status. Prev Chronic Dis. 2009 Oct. 6(4):A114.
- Shaw JE, Hodge AM, deCoruten M, Dowse GK, Gareeboo H, Tuomilehto J et al.; Diabetic peripheral neuropathy in Mauritius: Prevalence and risk factors. Diabetes Res Clin Pract. 1998; 43(2):131-139. https://doi.org/10.1016/S01688227(98)00100-4
- Kasturi AS, Yadhav RPS, Kurian G, Gupta MM. Cardiac autonomic neuropathy in diabetes mellitus. JAPI. 1991; 39(11):477
- Study to Evaluate Correlation between Serum Uric Acid Levels and Severity of Coronary Artery Disease in Patients Undergoing Coronary Angiography at Tertiary Health Care Centre
Abstract Views :116 |
PDF Views:55
Authors
Affiliations
1 Associate Professor, Professor, Department of Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, Maharashtra, IN
2 Former PG Resident, Professor, Department of Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, Maharashtra, IN
3 Professor, Department of Medicine, Dr. Vasantrao Pawar Medical College Hospital and Research Centre, Nashik – 422003, Maharashtra, IN
1 Associate Professor, Professor, Department of Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, Maharashtra, IN
2 Former PG Resident, Professor, Department of Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, Maharashtra, IN
3 Professor, Department of Medicine, Dr. Vasantrao Pawar Medical College Hospital and Research Centre, Nashik – 422003, Maharashtra, IN
Source
MVP Journal of Medical Sciences, Vol 8, No 2 (2021), Pagination: 283–288Abstract
Background: Coronary heart disease constitutes an immense public health problem. Myocardial Infarction is one of kind components of cardio vascular disease burden all around the world. Aim: Many epidemiologic studies have shown raised uric acid levels to predict increased risk of cardiovascular events. Studies have addressed the value of this biomarker across the whole range of patients with ACS (Acute Coronary Syndrome) especially in Indian scenarios. Thus, the aim of this study was to investigate whether there is an association between serum uric acid level with CAD (Coronary Artery Disease) risk factors and its severity in ACS patients. Also to know the prognostic value of serum uric acid levels in those patients undergoing coronary angiography for underlying coronary artery diseases. Material and Methods: This prospective observational study included 200 random patients admitted with Acute Coronary Syndrome in the ICU and medicine department of the institution. The presence and severity of CAD was determined by the following clinical vessel score; Absent: No coronary lesions, 1 vessel, 2 vessels and 3 vessels - disease based on the number of coronary arteries involved. The correlation of serum uric acid levels with CAD risk factors and the severity of CAD in the ACS patients was analysed statistically. Results: There was a significant association between uric acid and the coronary angiographic findings (P<0.001). The patients in the hyperuricemia group had more number of coronary vessels involved than the other group. Conclusion: The serum uric acid level is correlated with the presence and severity of CAD by coronary angiographic findings (P<0.001) in the Acute Coronary Syndrome patients. Uric acid being an inexpensive and easily available biochemical marker, it will be of much use in settings with restricted resources. Serum uric acid levels can be used to predict the severity of CAD.Keywords
ACS (Acute Coronary Syndrome), CAD (Coronary Artery Disease), HyperurecemiaReferences
- Kolansky DM. Acute Coronary Syndromes: morbidity, mortality and pharmaco economic burden. Am J Manag Care. 2009; 15(suppl):S36–4. PMid: 19286476. https://doi.org/10.1016/j.yebeh.2009.03.006
- Alpert JS, et al. Definition of myocardial infarction-a global consensus document of The Joint ESC/ACC/AHA/WHF/ WHO Task Force. 2007 (in press).
- BirnbaumY, Chamoun AJ, Anzuini A, Lick SD, Ahmad M, Uretsky BF: Ventricular free wall rupture following acute myocardial infarction. Coron Artery Dis. 2003; 14:463–70. PMid: 12966268. https://doi.
- org/10.1097/00019501-200309000-00008
- Reynen K, Strasser RH. Images in clinical medicine.
- Impending rupture of the myocardial wall. N Engl J Med.
- ; 348:e3. PMid: 12621147. https://doi.org/10.1056/ ENEJMicm020410
- Gertler MM, Garn SM, Levine SA. Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med. 1951; 34:1421. PMid: 14838504.
- https://doi.org/10.7326/0003-4819-34-6-1421
- Kohn PM, Prozan GB. Hyperuricemia-relationship to hypercholesterolemia and acute myocardial infarction.
- JAMA. 1959; 170:1909. PMid: 13672785. https://doi.
- org/10.1001/jama.1959.03010160025007
- Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study. Ann Intern Med. 1999; 131:7–13.
- PMid: 10391820. https://doi.org/10.7326/0003-4819-1311-199907060-00003
- Master AM. Acute coronary artery diseases; history, incidence, differential diagnosis and occupational significance. Am J Med. 1947 May; 2(5):501–16.
- doi:10.1016/0002-9343(47)90096-x.PMID:20294530
- https://doi.org/10.1016/0002-9343(47)90096-X
- Rusnak J, Fastner C, Behnes M, Mashayekhi K, Borggrefe M, Akin I. Biomarkers in Stable Coronary Artery Disease.
- Curr Pharm Biotechnol. 2017;18(6):456-–71. doi:10.2174/1 389201018666170630120805.PMID:28669333
- Leyva F, Anker SD, Godsland IF. Uric acid in chronic heart failure: A marker of chronic inflammation. European Heart Journal. 1998; 19(12):1814–22. PMid: 9886724. https://doi.
- org/10.1053/euhj.1998.1188
- Schmidt MI, Watson RL, Duncan BB, et al. Clustering of dyslipidemia, hyperuricemia, diabetes and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis risk in communities study investigators. Metabolism.
- ; 45(3):699–706. https://doi.org/10.1016/S00260495(96)90134-1
- Demir B, Caglar IM, Ugurlucan M, Ozde C, Oktay Tureli H, Ciftci S. The relationship between severity of Calcific Aortic Stenosis and Serum Uric Acid Levels.
- Angiology. 2012; 63(8):603–8. PMid: 22261436. https://doi.
- org/10.1177/0003319711433198
- Kojima S, Sakamoto T, Ishihara M, Kimura K, Miyazaki S,Yamagishi M. Prognostic usefulness of serum uric acid after acute Myocardial Infarction (the Japanese Acute Coronary Syndrome Study). Am J Cardiol. 2005; 96(4):489–95. PMid: 16098298. https://doi.org/10.1016/j.
- amjcard.2005.04.007
- Nadkar MY, JainVI. Serum Uric Acid in Acute Myocardial Infarction. JAPI. 2008; 56(1):759–62. https://doi.
- org/10.1057/mds.2009.50
- Baruah M, Nath CK, Chaudhury M, Devi R, Shaker A, Ivvala. Astudy of Serum Uric Acid and C-Reactive Protein in Acute Myocardial Infarction. International J of Basic Medical Sciences and Pharmacy. 2012; 2(1):21–4.
- Kojima S, Sakamoto T, Ishihara M, et al. Prognostic usefulness of serum uric acid after acute Myocardial Infarction (Japanese Acute Coronary Syndrome).